Searchlight: Centaur Pharma charts recovery after regulatory setbacks
Stay Home. Read Quality News
Advertisement
  • Home
  • Healthcare
  • Searchlight: Centaur Pharma charts recovery after regulatory setbacks

Searchlight: Centaur Pharma charts recovery after regulatory setbacks

By Roshan Abraham

  • 16 Mar 2026
Premium
Searchlight: Centaur Pharma charts recovery after regulatory setbacks
Credit: Pexels

In 2023, the US Food and Drug Administration (USFDA) warned Centaur Pharmaceuticals Pvt Ltd for failing to meet quality ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Become a Premium member
Already a member? Click here to log in.
Advertisement

Related Articles

Everstone to invest $270 mn in drugmaker Apothecon

Healthcare

Everstone to invest $270 mn in drugmaker Apothecon

Premium
Quadria Capital plans partial exit from three-year-old healthcare bet

Healthcare

Quadria Capital plans partial exit from three-year-old healthcare bet

Premium
VC-backed Orange Health looks to boost growth, expand physical footprint

Healthcare

VC-backed Orange Health looks to boost growth, expand physical footprint

Pro
Global PE firms vying to acquire a majority stake in Accord Hospital

Healthcare

Global PE firms vying to acquire a majority stake in Accord Hospital

Premium
PE-backed Redcliffe Labs sells IVF arm to Coca-Cola bottler

Healthcare

PE-backed Redcliffe Labs sells IVF arm to Coca-Cola bottler

Pro
ChrysCapital in final stages to back local drugmaker

Healthcare

ChrysCapital in final stages to back local drugmaker

Max Healthcare to buy Odisha hospital in east India foray

Healthcare

Max Healthcare to buy Odisha hospital in east India foray

Advertisement
Google News Icon

Google News

Follow VCCircle on Google News for the latest updates on Business and Startup News

FOLLOW